Persistent URL of this record https://hdl.handle.net/1887/110429
In Collections
This item can be found in the following collections:
![Phase I, Double-blind, Randomized, Placebo-controlled, Dose-escalation Study of NI-0401 (a Fully Human Anti-CD3 Monoclonal Antibody) in Patients with Moderate to Severe Active Crohn's Disease](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Phase I, Double-blind, Randomized, Placebo-controlled, Dose-escalation Study of NI-0401 (a Fully Human Anti-CD3 Monoclonal Antibody) in Patients with Moderate to Severe Active Crohn's Disease
- All authors
- Woude, C.J. van der; Stokkers, P.; Bodegraven, A.A. van; Assche, G. van; Hebzda, Z.; Paradowski, L.; D'Haens, G.; Ghosh, S.; Feagan, B.; Rutgeerts, P.; Dijkstra, G.; Jong, D.J. de; Oldenburg, B.; Farhan, M.; Richard, T.; Dean, Y.; Hommes, D.W.; ICC
- Date
- 2010-10-31
- Journal
- Inflammatory Bowel Diseases
- Volume
- 16
- Issue
- 10
- Pages
- 1708 - 1716